These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 36753806
1. Tissue-resident memory T cells in the multiple sclerosis brain and their relationship to Epstein-Barr virus infected B cells. Serafini B, Rosicarelli B, Veroni C, Aloisi F. J Neuroimmunol; 2023 Mar 15; 376():578036. PubMed ID: 36753806 [Abstract] [Full Text] [Related]
2. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism. Serafini B, Rosicarelli B, Veroni C, Mazzola GA, Aloisi F. J Virol; 2019 Dec 15; 93(24):. PubMed ID: 31578295 [Abstract] [Full Text] [Related]
3. EBV infected cells in the multiple sclerosis brain express PD-L1: How the virus and its niche may escape immune surveillance. Serafini B, Benincasa L, Rosicarelli B, Aloisi F. J Neuroimmunol; 2024 Apr 15; 389():578314. PubMed ID: 38422689 [Abstract] [Full Text] [Related]
4. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, Cinque P, Andreoni L, Trivedi P, Salvetti M, Faggioni A, Aloisi F. J Exp Med; 2007 Nov 26; 204(12):2899-912. PubMed ID: 17984305 [Abstract] [Full Text] [Related]
5. Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation. Serafini B, Severa M, Columba-Cabezas S, Rosicarelli B, Veroni C, Chiappetta G, Magliozzi R, Reynolds R, Coccia EM, Aloisi F. J Neuropathol Exp Neurol; 2010 Jul 26; 69(7):677-93. PubMed ID: 20535037 [Abstract] [Full Text] [Related]
6. The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis. Veroni C, Aloisi F. Front Immunol; 2021 Jul 26; 12():665718. PubMed ID: 34305896 [Abstract] [Full Text] [Related]
7. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Willis SN, Stadelmann C, Rodig SJ, Caron T, Gattenloehner S, Mallozzi SS, Roughan JE, Almendinger SE, Blewett MM, Brück W, Hafler DA, O'Connor KC. Brain; 2009 Dec 26; 132(Pt 12):3318-28. PubMed ID: 19638446 [Abstract] [Full Text] [Related]
9. B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis. Magliozzi R, Serafini B, Rosicarelli B, Chiappetta G, Veroni C, Reynolds R, Aloisi F. J Neuropathol Exp Neurol; 2013 Jan 26; 72(1):29-41. PubMed ID: 23242282 [Abstract] [Full Text] [Related]
10. Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes. Pender MP, Csurhes PA, Pfluger CM, Burrows SR. BMC Neurol; 2011 Aug 03; 11():95. PubMed ID: 21810280 [Abstract] [Full Text] [Related]
11. Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis. Veroni C, Serafini B, Rosicarelli B, Fagnani C, Aloisi F. J Neuroinflammation; 2018 Jan 16; 15(1):18. PubMed ID: 29338732 [Abstract] [Full Text] [Related]
12. White matter lesions in multiple sclerosis are enriched for CD20dim CD8+ tissue-resident memory T cells. Hsiao CC, Fransen NL, van den Bosch AMR, Brandwijk KIM, Huitinga I, Hamann J, Smolders J. Eur J Immunol; 2021 Feb 16; 51(2):483-486. PubMed ID: 32949467 [Abstract] [Full Text] [Related]
13. Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies. Fernández-Menéndez S, Fernández-Morán M, Fernández-Vega I, Pérez-Álvarez A, Villafani-Echazú J. J Neurol Sci; 2016 Feb 15; 361():213-9. PubMed ID: 26810546 [Abstract] [Full Text] [Related]
14. Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis. Pender MP, Csurhes PA, Lenarczyk A, Pfluger CM, Burrows SR. J Neurol Neurosurg Psychiatry; 2009 May 15; 80(5):498-505. PubMed ID: 19015225 [Abstract] [Full Text] [Related]
15. Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions. Fransen NL, Hsiao CC, van der Poel M, Engelenburg HJ, Verdaasdonk K, Vincenten MCJ, Remmerswaal EBM, Kuhlmann T, Mason MRJ, Hamann J, Smolders J, Huitinga I. Brain; 2020 Jun 01; 143(6):1714-1730. PubMed ID: 32400866 [Abstract] [Full Text] [Related]
16. Massive intracerebral Epstein-Barr virus reactivation in lethal multiple sclerosis relapse after natalizumab withdrawal. Serafini B, Scorsi E, Rosicarelli B, Rigau V, Thouvenot E, Aloisi F. J Neuroimmunol; 2017 Jun 15; 307():14-17. PubMed ID: 28495131 [Abstract] [Full Text] [Related]
17. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Sargsyan SA, Shearer AJ, Ritchie AM, Burgoon MP, Anderson S, Hemmer B, Stadelmann C, Gattenlöhner S, Owens GP, Gilden D, Bennett JL. Neurology; 2010 Apr 06; 74(14):1127-35. PubMed ID: 20220124 [Abstract] [Full Text] [Related]
18. Epstein-Barr virus and multiple sclerosis. Salvetti M, Giovannoni G, Aloisi F. Curr Opin Neurol; 2009 Jun 06; 22(3):201-6. PubMed ID: 19359987 [Abstract] [Full Text] [Related]
19. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis. Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A, Kleeberg J, Le Goff G, Pantaleo G, Du Pasquier RA. Brain; 2008 Jul 06; 131(Pt 7):1712-21. PubMed ID: 18550621 [Abstract] [Full Text] [Related]